Detalhe da pesquisa
1.
Reconsidering frailty from a human and social sciences standpoint: towards an interdisciplinary approach to vulnerability.
Age Ageing
; 52(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130592
2.
Polyhydroxyalkanoate synthesis affects biosurfactant production and cell attachment to hydrocarbons in Pseudomonas sp. KA-08.
Curr Microbiol
; 68(6): 735-42, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24519857
3.
Flavouring group evaluation 419 (FGE.419): 2-methyl-1-(2-(5-(p-tolyl)-1H-imidazol-2-yl)piperidin-1-yl)butan-1-one.
EFSA J
; 22(5): e8750, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711805
4.
Scientific opinion on the renewal of the authorisation of Smoke Concentrate 809045 (SF-003) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08365, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027427
5.
Scientific opinion on the renewal of the authorisation of Zesti Smoke Code 10 (SF-002) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08364, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027431
6.
Scientific opinion on the renewal of the authorisation of Fumokomp (SF-009) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08370, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027436
7.
Scientific opinion on the renewal of the authorisation of SmokEz C-10 (SF-005) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08367, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027441
8.
Scientific opinion on the renewal of the authorisation of SmokEz Enviro-23 (SF-006) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08368, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027452
9.
Scientific opinion on the renewal of the authorisation of Scansmoke SEF7525 (SF-004) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08366, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027432
10.
Scientific opinion on the renewal of the authorisation of proFagus Smoke R714 (SF-001) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08363, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027451
11.
Scientific opinion on the renewal of the authorisation of proFagus Smoke R709 (SF-008) as a smoke flavouring Primary Product.
EFSA J
; 21(11): e08369, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027454
12.
Genome sequence of the polyhydroxybutyrate producer Pseudomonas extremaustralis, a highly stress-resistant Antarctic bacterium.
J Bacteriol
; 194(9): 2381-2, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22493195
13.
Biofilm lifestyle enhances diesel bioremediation and biosurfactant production in the Antarctic polyhydroxyalkanoate producer Pseudomonas extremaustralis.
Biodegradation
; 23(5): 645-51, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22302594
14.
TGF-alpha mediates genetic susceptibility to chronic kidney disease.
J Am Soc Nephrol
; 22(2): 327-35, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21183591
15.
GPs' interest in integrated care for frail older adults and corresponding consulting and prescribing data: qualitative and quantitative analyses of the PAERPA integrated care project.
Br J Gen Pract
; 72(724): e809-e815, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192356
16.
Scientific opinion on Prosmoke BW 01.
EFSA J
; 20(5): e07299, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35646165
17.
Evaluation of the safety and efficacy of lactic acid to reduce microbiological surface contamination on carcases from kangaroos, wild pigs, goats and sheep.
EFSA J
; 20(5): e07265, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35592024
18.
Scientific opinion on Flavouring group evaluation 216 revision 2 (FGE.216Rev2): consideration of the genotoxicity potential of α,ß-unsaturated 2-phenyl-2-alkenals from subgroup 3.3 of FGE.19.
EFSA J
; 20(8): e07420, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35991962
19.
Scientific Guidance on the data required for the risk assessment of flavourings to be used in or on foods.
EFSA J
; 20(12): e07673, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579172
20.
Barriers and Facilitators in the Uptake of Integrated Care Pathways for Older Patients by Healthcare Professionals: A Qualitative Analysis of the French National "Health Pathway of Seniors for Preserved Autonomy" Pilot Program: Barriers and Facilitators for Adhesion of Healthcare Professionals in Integrated Care for Older Patients: A Qualitative Assessment Based on the French National Experiment: 'Health Pathway of Seniors for Preserved Autonomy' (PAERPA).
Int J Integr Care
; 21(2): 7, 2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976596